Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age.

Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age.
复制标题

DOI:
10.1002/hep4.1602
复制
发表时间:
2020-12
影响因子:
5.1
通讯作者:
Childhood Liver Disease Research Network
Childhood Liver Disease Research Network
中科院分区:
医学2区
文献类型:
--
作者:
Venkat V;Ng VL;Magee JC;Ye W;Hawthorne K;Harpavat S;Molleston JP;Murray KF;Wang KS;Soufi N;Bass LM;Alonso EM;Bezerra JA;Jensen MK;Kamath BM;Loomes KM;Mack CL;Rosenthal P;Shneider BL;Squires RH;Sokol RJ;Karpen SJ;Childhood Liver Disease Research Network

文献摘要

参考文献

被引文献

相似文献

Approximately 50% of infants with biliary atresia (BA) undergoing Kasai portoenterostomy show survival with native liver (SNL) at age 2 years. Predictors of disease progression after age 2 years are unknown, despite estimates of 20%‐30% undergoing liver transplant (LT) between age 2 and 18 years. We sought to address this knowledge gap by developing prognostic models in participants of the multicenter prospective National Institutes of Health‐supported Childhood Liver Disease Research Network. We extracted 14 clinical and biochemical variables at age 2 years to develop two models for future outcomes: 1) LT or death (LTD) and 2) first sentinel event (SE), either new onset ascites, hepatopulmonary syndrome (HPS), or gastrointestinal (GI) bleed. A total of 240 participants, enrolled between 2004 and 2017, were followed until a median age of 5.1 years (range, 2.0‐13.3 years). Of these participants, 38 underwent LT (n = 37) or death (n = 1); cumulative incidence, 23.7% (95% confidence interval [CI], 16.2%‐32.0%). Twenty‐seven experienced either new‐onset ascites (n = 13), HPS (n = 1), or GI bleed (n = 14). One participant had ascites and GI bleed concurrently; cumulative incidence, 21.5% (95% CI, 14.2%‐29.8%) by age 10 years. The Cox proportional hazard model predicted risk of LTD, using total bilirubin, albumin, platelet count, and history of either ascites or cholangitis (BA LTD model), with a C‐index of 0.88 (range, 0.86‐0.89). A cause‐specific hazard competing risk model predicted SE using platelet count and gamma glutamyltransferase levels (BA SE model) with a C‐index of 0.81 (range, 0.80‐0.84). Internal model validity was assessed using Harrell’s C‐index with cross‐validation. Conclusion: Stratification using these models identified risk of poor outcomes in patients with BA SNL after age 2 years. The models may identify those who would benefit from enhanced clinical surveillance and prioritization in clinical trials.
DOI: 10.1097/mpg.0000000000002256
发表时间: 2019-04-01
影响因子: 2.9
作者:
Mack, Cara L;Spino, Cathie;Sokol, Ronald J
通讯作者: Sokol, Ronald J
DOI: 10.1016/j.jpedsurg.2018.10.060
发表时间: 2019-07-01
影响因子: 2.4
作者:
Parolini, Filippo;Boroni, Giovanni;Alberti, Daniele
通讯作者: Alberti, Daniele
DOI: 10.1053/j.gastro.2011.08.049
发表时间: 2011-12-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Cristobal Gana, Juan;Turner, Dan;Ling, Simon C.
通讯作者: Ling, Simon C.
DOI: 10.1016/j.jpedsurg.2004.08.021
发表时间: 2004-12-01
影响因子: 2.4
作者:
Nio, M;Sano, N;Ohi, R
通讯作者: Ohi, R
DOI: 10.1158/1078-0432.ccr-11-2097
发表时间: 2012-04-15
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Dignam JJ;Zhang Q;Kocherginsky M
通讯作者: Kocherginsky M